| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36c66685971b78daf233b5999ead4c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7755e5feca07c73e2fbbc94c392018af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b5454abd09f216530c44daae0e81afa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 |
| filingDate |
2019-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e57a6935a8887f2b77195daf627a537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53ed30ea34325bb305c24450daa0f5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf748a7d946922794bd1bb0d6782df32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc4be90a65bad9b804690f85e1abaee0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a91693c18e6a4237fee50af73960b351 |
| publicationDate |
2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202015716-A |
| titleOfInvention |
KOR receptor agonist pharmaceutical composition |
| abstract |
The disclosure provides a pharmaceutical composition of KOR receptor agonist. Specifically, the disclosure provides the pharmaceutical composition of KOR receptor agonist contains 4-amino- N -[ N 2 -[ N -[ N -[ N -(( R )-2-phenylpropyl)glycyl]-D-phenylalanyl]-D-leucyl]-D-lysyl]piperidine-4-carboxylic acid or its pharmaceutical salts and acetate buffers. The pharmaceutical composition of the disclosure shows good stability after several months of storage. |
| priorityDate |
2018-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |